Theralase Technologies Inc. V.TLT

Warrant $$$ coming soon

[cashascars]

No Need to be concerned about money trouble.

May 14 2022 

5.1 million warrants @.30  exp and will be excercised bringing in.

$1,500,0000 

Oct 3 2022

3.15 million warrants @.50 exp and should be excercised if price gets over that threshold which seem unlikely that it will not, bringing in another.

$1,575,000

Jan 8 2023

4.1 million warrants @.50 exp bringing in another.

$2,050,000

That will be more than enough to get us to the tradeable warrants @.35 that will bring in around 

$18,000,000

With every quarterly looking better than the one before we will have a very good year.

Remember I am a very optomistic guy, but I really don't see any major problems that can upset this cart. 
cashascars

[floatinketucky]

Probably just enough warrats exercied by friendlys keep the ops running nicley. The others will go to V.TLT.W.  Partner ships with Candian Gov. and grants may assist.  Perhaps St. Michaels is very interested in support.  How did they treat theralase so far??  LOL As well as many others Friendly offers may abound very soon.  H.C Wainright was in the meeting a while ago

[menoalittle]

close, and point taken... but don't think those May numbers are quite right, cashascars. As of Nov. 29, there were only 3,159,000 of the May 14, 2022 warrants still outstanding, which puts max. possible additional cash from them at  $947,700. However, the total outstanding 50 cent Oct. 3, 2022 and Jan. 9, 2023 warrants are very close. (and not that it makes much difference given TLT is

[cashascars]

Thanks meno I appreciate your updated numbers. cashascars

[Oilminerdeluxe]

Start the freaking GBM trial. Patience, breathe, patience, breathe.

[ScienceFirst]

Just like we have done them in order to proceed with a Ph. 1b with TLD-1433, there are at least  things that must be fulfilled for each GBM and NSCLC trials in order to move further: 1) A MSAB has to back the design of each of these trials.  Just like we onboarded urology specialists like Dr. Kamat, Dr, OMDonnell, Dr. Jewett, etc ...  So we'll have to see pulmonary and brain

[99942Apophis]

Good points ScienceFirst. Stated in the news release of Dec 9/21 Arkady Mandel again discussed GBM & NSCLC which leads me to believe within 6  months we will see the start of movement towards PH1 of both indications unless this Covid-19 continues to slow progression of NMIBC with enrollment.  Arkady Mandel, M.D., Ph.D., D.Sc., Interim Chief Executive Officer (“CEO”) and Chief

[CancerSlayer]

  Good points, & as stated in one of Dr. Madzarevic's bios... "Dr. Madzarevic´s particular expertise is centered on internal and pre-regulatory GCP, GLP, and CLIA pre-certification inspections, clinical trial management, drug development programs, quality assurance, and professional training." And her last notable work, Clinical Trials Audit Preparation:  A

[ScienceFirst]

Nice observtion that I forwarded to TLT.  At least, we have the email of Dr. Mandel, in the meantime. Contacts Contact: Shawn Shirazi, Ph.D 416-699-5273 ext 229 [e-mail]   Contact: Arkady Mandel, MD, Ph.D. 416-699-5273 ext 242 [e-mail]

[patience69]

It appears that there is a general consensus that we have the right person for the job. I could not agree more. One silly little question rocking around in my head is who will she actually be employed by??? Theralase or............